PL362078A1 - Sposób i pochodne estrowe użyteczne w sposobie wytwarzania cefalosporyn - Google Patents
Sposób i pochodne estrowe użyteczne w sposobie wytwarzania cefalosporynInfo
- Publication number
- PL362078A1 PL362078A1 PL01362078A PL36207801A PL362078A1 PL 362078 A1 PL362078 A1 PL 362078A1 PL 01362078 A PL01362078 A PL 01362078A PL 36207801 A PL36207801 A PL 36207801A PL 362078 A1 PL362078 A1 PL 362078A1
- Authority
- PL
- Poland
- Prior art keywords
- cephalosporins
- preparation
- ester derivatives
- derivatives useful
- useful
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 150000001780 cephalosporins Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/08—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
- C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25101800P | 2000-12-04 | 2000-12-04 | |
| PCT/IB2001/002181 WO2002046199A1 (en) | 2000-12-04 | 2001-11-19 | Process and ester derivatives useful for preparation of cephalosporins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL362078A1 true PL362078A1 (pl) | 2004-10-18 |
Family
ID=22950131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01362078A PL362078A1 (pl) | 2000-12-04 | 2001-11-19 | Sposób i pochodne estrowe użyteczne w sposobie wytwarzania cefalosporyn |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20020099205A1 (pl) |
| EP (1) | EP1339723B1 (pl) |
| JP (1) | JP2004515503A (pl) |
| KR (1) | KR100526380B1 (pl) |
| CN (1) | CN1243756C (pl) |
| AR (1) | AR035076A1 (pl) |
| AT (1) | ATE319719T1 (pl) |
| AU (2) | AU2002223929B2 (pl) |
| BR (1) | BR0115872A (pl) |
| CA (1) | CA2436863C (pl) |
| CY (1) | CY1104995T1 (pl) |
| CZ (1) | CZ20031526A3 (pl) |
| DE (1) | DE60117876T2 (pl) |
| DK (1) | DK1339723T3 (pl) |
| ES (1) | ES2257471T3 (pl) |
| HK (1) | HK1059265A1 (pl) |
| HU (1) | HUP0400686A3 (pl) |
| IL (1) | IL155701A0 (pl) |
| MX (1) | MXPA03004938A (pl) |
| PL (1) | PL362078A1 (pl) |
| PT (1) | PT1339723E (pl) |
| RU (1) | RU2237671C1 (pl) |
| WO (1) | WO2002046199A1 (pl) |
| ZA (1) | ZA200303498B (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL362144A1 (pl) * | 2000-12-04 | 2004-10-18 | Pfizer Products Inc. | Sposób sprzęgania i związki pośrednie użyteczne wsposobie wytwarzania cefalosporyn |
| KR100830754B1 (ko) * | 2004-03-09 | 2008-05-19 | 화이자 프로덕츠 인코포레이티드 | α-요오도-1-아제티딘아세트산 에스테르 및 트라이알킬포스파이트를 이용한 세팔로스포린 중간체의 제조방법 |
| AU2005225626B2 (en) * | 2004-03-09 | 2008-03-13 | Pfizer Products Inc. | Process for preparing cephalosporin intermediates using alpha-iodo-1-azetidineacetic acid esters and trialkylphosphites |
| EP1951723B1 (en) | 2005-10-20 | 2017-08-30 | Postech Academy-Industry Foundation | The application using non-covalent bond between a cucurbituril derivative and a ligand |
| CN102372738B (zh) * | 2010-08-14 | 2017-11-10 | 武汉工程大学 | Lj反应在制备维蒂希试剂和草铵膦中的应用 |
| CN105254648B (zh) * | 2015-11-13 | 2018-04-03 | 广东温氏大华农生物科技有限公司 | 一种头孢维星及其钠盐的合成方法 |
| GB2575261B (en) | 2018-07-02 | 2022-03-09 | Norbrook Lab Ltd | Intermediates in the synthesis of C3-substituted cephalosporins |
| CN111892612A (zh) * | 2020-07-31 | 2020-11-06 | 重庆医药高等专科学校 | 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法 |
| CN117186116B (zh) * | 2023-09-07 | 2024-06-07 | 浙江荣耀生物科技股份有限公司 | 一种头孢维星中间体的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY106399A (en) * | 1990-07-24 | 1995-05-30 | Pfizer | Cephalosporins and homologeus, preparation and pharmaceutical composition |
| US6020329A (en) * | 1990-07-24 | 2000-02-01 | Pzifer Inc. | Cephaloporins and homologues, preparations and pharmaceutical compositions |
| US6001997A (en) * | 1990-07-24 | 1999-12-14 | Bateson; John Hargreaves | Cephalosporins and homologues, preparations and pharmaceutical compositions |
| GB9212609D0 (en) * | 1992-06-13 | 1992-07-29 | Smithkline Beecham Plc | Novel compounds |
| GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
| GB2300856A (en) * | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
-
2001
- 2001-11-19 JP JP2002547936A patent/JP2004515503A/ja active Pending
- 2001-11-19 DK DK01999226T patent/DK1339723T3/da active
- 2001-11-19 MX MXPA03004938A patent/MXPA03004938A/es active IP Right Grant
- 2001-11-19 AU AU2002223929A patent/AU2002223929B2/en not_active Ceased
- 2001-11-19 PT PT01999226T patent/PT1339723E/pt unknown
- 2001-11-19 AU AU2392902A patent/AU2392902A/xx active Pending
- 2001-11-19 CA CA002436863A patent/CA2436863C/en not_active Expired - Fee Related
- 2001-11-19 AT AT01999226T patent/ATE319719T1/de not_active IP Right Cessation
- 2001-11-19 BR BR0115872-4A patent/BR0115872A/pt not_active IP Right Cessation
- 2001-11-19 DE DE60117876T patent/DE60117876T2/de not_active Expired - Fee Related
- 2001-11-19 CN CNB018195792A patent/CN1243756C/zh not_active Expired - Fee Related
- 2001-11-19 CZ CZ20031526A patent/CZ20031526A3/cs unknown
- 2001-11-19 KR KR10-2003-7007397A patent/KR100526380B1/ko not_active IP Right Cessation
- 2001-11-19 PL PL01362078A patent/PL362078A1/pl unknown
- 2001-11-19 HU HU0400686A patent/HUP0400686A3/hu unknown
- 2001-11-19 ES ES01999226T patent/ES2257471T3/es not_active Expired - Lifetime
- 2001-11-19 RU RU2003116520/04A patent/RU2237671C1/ru not_active IP Right Cessation
- 2001-11-19 WO PCT/IB2001/002181 patent/WO2002046199A1/en active IP Right Grant
- 2001-11-19 IL IL15570101A patent/IL155701A0/xx unknown
- 2001-11-19 EP EP01999226A patent/EP1339723B1/en not_active Expired - Lifetime
- 2001-12-03 AR ARP010105608A patent/AR035076A1/es active IP Right Grant
- 2001-12-04 US US10/006,579 patent/US20020099205A1/en not_active Abandoned
-
2003
- 2003-05-07 ZA ZA200303498A patent/ZA200303498B/en unknown
-
2004
- 2004-02-17 US US10/781,158 patent/US20040267008A1/en not_active Abandoned
- 2004-03-24 HK HK04102181A patent/HK1059265A1/xx not_active IP Right Cessation
-
2006
- 2006-03-15 CY CY20061100361T patent/CY1104995T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR035076A1 (es) | 2004-04-14 |
| ES2257471T3 (es) | 2006-08-01 |
| HK1059265A1 (en) | 2004-06-25 |
| AU2002223929B2 (en) | 2007-08-23 |
| WO2002046199A8 (en) | 2003-06-12 |
| HUP0400686A3 (en) | 2010-03-29 |
| DE60117876D1 (de) | 2006-05-04 |
| ZA200303498B (en) | 2004-05-07 |
| EP1339723A1 (en) | 2003-09-03 |
| PT1339723E (pt) | 2006-06-30 |
| RU2237671C1 (ru) | 2004-10-10 |
| HUP0400686A2 (hu) | 2004-06-28 |
| AU2392902A (en) | 2002-06-18 |
| CA2436863C (en) | 2007-05-22 |
| EP1339723B1 (en) | 2006-03-08 |
| IL155701A0 (en) | 2003-11-23 |
| CY1104995T1 (el) | 2009-11-04 |
| US20020099205A1 (en) | 2002-07-25 |
| KR20030070044A (ko) | 2003-08-27 |
| DK1339723T3 (da) | 2006-06-12 |
| JP2004515503A (ja) | 2004-05-27 |
| DE60117876T2 (de) | 2006-08-31 |
| US20040267008A1 (en) | 2004-12-30 |
| CN1478094A (zh) | 2004-02-25 |
| CA2436863A1 (en) | 2002-06-13 |
| MXPA03004938A (es) | 2003-09-10 |
| WO2002046199A1 (en) | 2002-06-13 |
| BR0115872A (pt) | 2003-10-28 |
| CN1243756C (zh) | 2006-03-01 |
| CZ20031526A3 (en) | 2004-04-14 |
| KR100526380B1 (ko) | 2005-11-08 |
| ATE319719T1 (de) | 2006-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL193405A0 (en) | Process for the preparation of dihydroxy esters and derivatives thereof | |
| PL360699A1 (pl) | Sposób wytwarzania kwasu N-arylo-antranilowego i jego pochodnych | |
| HUP0202435A3 (en) | Process for the preparation of naproxene nitroxyalkylesters | |
| IL152580A0 (en) | Process for the preparation of indole derivatives and intermediates of the process | |
| HK1059265A1 (en) | Process and ester derivatives useful for preparation of cephalosporins | |
| AU2002222553A1 (en) | Process for producing anhydride of aminothiazole derivative | |
| IL146580A0 (en) | Method of producing nitroguanidine-and nitroenamine derivatives | |
| IL152224A0 (en) | Stable crystals of thiazolidinedione derivative and process for the preparation thereof | |
| HUP0100743A3 (en) | Process for preparation of simvastatin and derivatives thereof | |
| HUP0203364A3 (en) | Method for preparation of 3-substituted-4-arylquinolin-2-one derivatives | |
| GB2363605B (en) | Process for the preparation of alpha-aminoketone derivatives | |
| PL357106A1 (pl) | Nowy sposób wytwarzania -(2,4-disulfofenylo)-N-tert-butylonitronu i jego farmaceutycznie dopuszczalnych soli | |
| AU2002210816A1 (en) | Process for preparation of beta-phenethylamine derivative | |
| AU5553200A (en) | Process for the preparation of paroxetine and structurally related compounds | |
| HUP0202819A3 (en) | Process for the preparation of thiazole derivatives and the new intermediates | |
| AU2001220267A1 (en) | Novel 1beta-methylcarbapenem derivatives and process of preparation thereof | |
| AU4585000A (en) | Process for the preparation of 5-amino-3-alkylisothiazole compounds and of 5-amino-4-chloro-3-alkylisothiazole compounds | |
| HU9904575D0 (en) | Process for preparation of n-alkoxy-methyl-acidamides | |
| AU2001270584A1 (en) | Process for the preparation of dipeptide derivatives | |
| HUP0301293A3 (en) | Process for the preparation of mycophenolic acid and derivatives thereof | |
| PL336061A1 (en) | Method of obtaining cephuroxime 1-acetoxyethylenic ester | |
| AU2002219435A1 (en) | Novel thioester derivatives and process for preparation of cephalosporin | |
| PL340277A1 (en) | Method of oxyethylenating esters | |
| PL340157A1 (en) | Method of obtaining derivatives of 2-phenyl-3-aminopyridine | |
| SI1056737T1 (en) | Process for the preparation of simvastatin and derivatives thereof |